2009
DOI: 10.1134/s1061934809010079
|View full text |Cite
|
Sign up to set email alerts
|

Detection of oxandrolone and its metabolite in urine by high-performance liquid chromatography-high-resolution mass spectrometry with atmospheric pressure chemical ionization and orbitrap detection after ceasing drug administration

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2009
2009
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(7 citation statements)
references
References 4 publications
0
7
0
Order By: Relevance
“…As the very first step, the presence of glucuronide and sulfate metabolic forms of OXA in the real samples was examined in order to unify possible OXA forms for the best analyte recovery. For this purpose, the urine samples were hydrolyzed enzymatically using β-glucuronidase, which provides both β-glucuronidase and arylsulfatase activity [ 35 ], according to the procedure described previously [ 31 ]. There were found no significant differences in OXA concentrations between the hydrolyzed samples and the samples prepared according to the procedure described in Section 3.4.3 .…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…As the very first step, the presence of glucuronide and sulfate metabolic forms of OXA in the real samples was examined in order to unify possible OXA forms for the best analyte recovery. For this purpose, the urine samples were hydrolyzed enzymatically using β-glucuronidase, which provides both β-glucuronidase and arylsulfatase activity [ 35 ], according to the procedure described previously [ 31 ]. There were found no significant differences in OXA concentrations between the hydrolyzed samples and the samples prepared according to the procedure described in Section 3.4.3 .…”
Section: Resultsmentioning
confidence: 99%
“…Viryus, et al [ 30 ] coupled high-resolution mass spectrometry (HRMS) (orbitrap) with HPLC via APCI for screening doping controls. The same group developed an HPLC-HRMS method enabling identification of OXA in the urine as long as two weeks after ending its 15-day administration [ 31 ]. Guddat, et al [ 32 ] used GC-MS/MS and LC-MS/MS for the identification of OXA and its metabolites in urine samples.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Urine samples were treated as described elsewhere with minimal modifications. Briefly, 1 mL of phosphate buffer (0.8 M, pH 6.3) containing 3% of β‐glucuronidase and 1.5 µg of methyltestosterone as internal standard was added to 3 mL of urine.…”
Section: Expepimentalmentioning
confidence: 99%
“…Low detection limits (3 × 10 -13 -1.2 × 10 -12 g) have been achieved in real samples. [97][98][99][100][101] Researchers from ADC have developed an approach allowing the maximization of the number of compounds that can be determined with high sensitivity in a single run. 102 It involves so-called "wrong-way-round ionization" in ESI for the simultaneous detection of multiple classes of doping substances (stimulants, diuretics, b 2 -agonists, b-blockers, antiestrogens, glucocorticosteroids and anabolic agents) without the need to switch the polarity.…”
Section: Doping-controlmentioning
confidence: 99%